Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Acceleron Pharma NASDAQ: XLRN-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 177.06
Day High 179.85
Open:179.85
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge, Massachusetts.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Hold

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Merck Completes Acquisition of Acceleron Pharma Inc.
Business Wire - Mon Nov 22, 5:45AM CST
Business Wire - PRTGAM
Mon Nov 22, 5:45AM CST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN).
Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
Business Wire - Fri Nov 19, 5:06PM CST
Business Wire - PRTGAM
Fri Nov 19, 5:06PM CST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, Astros Merger Sub, Inc., for all of the outstanding shares of common stock of Acceleron...
Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate Offer
Business Wire - Wed Nov 17, 1:26PM CST
Business Wire - PRTGAM
Wed Nov 17, 1:26PM CST
Avoro Capital Advisors (“Avoro”), a long-term and collaborative investor in life sciences and biotechnology companies, together with certain of its affiliates and managed funds (“Avoro,” “we” or “us”) beneficially owns approximately 7% of...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 172.25 +3.77% increase
on 10/20/21
Period Open:173.74
Price movement based on the high, low and last over the given period.
179.94 -0.66% decrease
on 11/17/21
+5.01 (+2.88%) increase
since 10/19/21
3-Month 120.20 +48.71% increase
on 08/20/21
Period Open:119.99
Price movement based on the high, low and last over the given period.
189.99 -5.92% decrease
on 09/29/21
+58.76 (+48.97%) increase
since 08/19/21
52-Week 108.82 +64.26% increase
on 11/20/20
Period Open:110.92
Price movement based on the high, low and last over the given period.
189.99 -5.92% decrease
on 09/29/21
+67.83 (+61.15%) increase
since 11/19/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies